Skip to main content
. 2020 Aug 12;6(1):137–145. doi: 10.1016/j.bioactmat.2020.07.007

Fig. 3.

Fig. 3

In vitro release behaviour and degradation behaviour of dual-peptide delivery scaffolds. (a) release behaviour of angiogenic peptide and osteogenic peptide in a 42-day test period; (b) weight remaining of dual-peptide delivery scaffolds and controls in an 8-week test period.